Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms

Pharm Biol. 2013 Jan;51(1):42-8. doi: 10.3109/13880209.2012.703678. Epub 2012 Sep 27.

Abstract

Context: The recent developments in non-viral gene therapy and DNA vaccine have fostered the development of efficient plasmid DNA (pDNA) purification processes.

Objectives: This work aimed to establish a cost-effective purification process for the large-scale production of plasmid DNA for gene therapy and DNA vaccine.

Materials and methods: E. coli DH5α harboring pCDNA3.1-GFP (7200 base pairs) was used as a model plasmid. Hydrophobic-interaction chromatography (HIC) was employed to purify supercoiled plasmid DNA (sc pDNA).

Results: With this method, not only host contaminants, but also open circular plasmid DNA (oc pDNA) could be removed from sc pDNA. Anion-exchange HPLC analysis proved that the recovery of HIC could reach 75%. The plasmid DNA exhibited high purity with supercoiled percentage of 98 ± 1.2% and undetectable residual endotoxins, genomic DNA, RNA and protein. The purity of pDNA had nothing to do with the flow rate in the range at least up to 400 cm/h. Liposomes transfection experiment prove that the purified pDNA in this article had higher transfection efficiency than the control pDNA.

Discussion and conclusion: In the present work, we confirmed the possibility of separation of sc pDNA from oc pDNA and other host contaminants using a single HIC chromatography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography / economics
  • Chromatography / methods*
  • Chromatography, High Pressure Liquid / methods
  • Cost-Benefit Analysis
  • DNA, Superhelical / isolation & purification*
  • Escherichia coli / genetics
  • Genetic Therapy / methods
  • Hydrophobic and Hydrophilic Interactions
  • Plasmids / isolation & purification*
  • Vaccines, DNA / administration & dosage

Substances

  • DNA, Superhelical
  • Vaccines, DNA